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Nuclear protein which selectively binds to the Am-family DNA repeat (AFR, Blur@ is partially purified from human 
HeLa cells using a gel retention assay. At low protein concentrations only a single complex of the protein with AFR 
is formed (CII). Increasing protein concentrations lead to the gradual disappearance of CII, being replaced by complexes 
with higher (CI) and lower (CIII, CIV) electrophoretic mobilities. Differential binding of AFR restriction subfragments 
indicates that multiple protein-binding sites are present within AFR. We discuss two models explaining the anomalous 
electrophoretic mobility of CII by DNA bending or looping upon cooperative multi-site binding of the protein to AFR. 
DNA-binding protein; Am-family DNA repeat 
1. INTRODUCTION 
The human genome contains 3-5 x 10’ dis- 
persed Alu-family DNA repeats (AFRs) which 
have a variable length of about 300 base pairs and 
vary in nucleotide sequence, having evolved from 
a large pool of precursors [l-3]. AFRs are sug- 
gested to be mobile genetic elements transposed 
when reverse-transcript AFR-precursors integrate 
preferentially into AT-rich regions [4-61. AFRs 
contain RNA polymerase III promoter [4] and 
lo-20% of all genomic AFRs are capable of being 
transcribed [3], but in HeLa cells AFRs are 
transcriptionally silent 171. It was also suggested 
that AFRs contain the origin of replication and are 
involved in the initiation of DNA synthesis [2,8]. 
The SV40 virus protein A (T-antigen) stimulates 
the initiation of DNA replication starting from 
AFR both in vivo and in vitro 19, lo]. T-antigen in- 
teracts with the pentanucleotide 5 ’ -GAGGC3 ’ 
[ll-131 which is present in AFR [3,14]. 
In our previous report [ 151 the Alu-family repeat 
binding protein (ABP) from HeLa cells was 
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described which also interacts with the regulatory 
region of the SV40 virus genome. In this paper 
data will be presented suggesting that AFR con- 
tains several binding sites for ABP, and that the 
major binding site is situated within the 35 bp 
NinfI subfragment which is homologous with the 
T-antigen binding site II at the SV40 replication 
origin. 
2. MATERIALS AND METHODS 
Methods for the growth of HeLa cells, isolation of 0.4 M 
NaCl nuclear extract, purification of plasmid DNAs, isolation 
and end-labelling of restriction fragments with the help of DNA 
polymerase have been described before [15]. 
For this study Am-binding protein (ABP) was purified as 
follows: 0.4 M NaCl nuclear extract from 3 g of wet cells was 
diluted to obtain 50 mM concentration of NaCl and applied to 
a column of DEAE-cellulose (1.5 x 13.0 cm) equilibrated with 
buffer A (15 mM Tris-Cl, pH 8, 0.1 mM EDTA, 0.5 mM 
dithiothreitol, 5% glycerol) containing 50 mM NaCl, and then 
the column was washed with the same buffer. Adsorbed pro- 
teins were eluted with a stepwise gradient of NaCl in buffer A: 
150 mM, 250 mM (DE250 fraction) and 350 mM. The DE250 
fraction containing ABP was dialysed against 20 mM Tris-HCl 
buffer, pH 8, and passed through the FPLC column MonoQ 
(HR 5/S, Pharmacia) which was then washed with the same 
buffer and with a linear gradient of NaCl (O-l M) in the same 
buffer. ABP is eluted at 0.4 M NaCl (MQ4m fraction). 
Incubation mixtures for the gel retention assay of DNA- 
binding proteins contained l-10 ng of end-labelled [32P]DNA 
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of short BumHI AFR fragment (or its subfragments produced 
by endonuclease HinfI) from plasmid Blur8 [14], 0.1% Triton 
X-100, 4% glycerol, ‘1 mM EDTA, 10 mM dithiothreitol, 
10 mM Tris-HCl buffer, pH 7.5), 150 mM NaCl, and different 
quantities of non-labelled non-Alu DNAs as indicated in 
legends to the figures. After incubation for 30 min at room 
temperature complexes were run in low salt 4% polyacrylamide 
gel [16,17], then gel was dried and radioautographed. 
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Fig. 1. Complexes formed by the protein (ABP) and Alu-family 
repeat. 0.5 ng of the short end-labelled (about 260 bp) BarnHI 
fragment from the plasmid Blur8 [14] was incubated with ABP 
(MQ4m fraction, 1 pg of protein) in the presence of 80 mM 
NaCl and increasing amounts (lO-, 20- and 50-fold molar 
excess, lanes 2, 3, and 4, respectively) of pBR322 DNA. After 
30’min samples were run in low salt polyacrylamide 4% gel 
[16]. Complexes CI, CII, CIII and CIV have electrophoretic 
mobilities relative to the free Alu-family repeat (lane 1) equal to 
0.73,0.57,0.45, and 0.34, respectively. 50-fold molar excess of 
pBR322 DNA corresponds to about 700-fold excess of the DNA 
Relative concentration of NAB-protein 
Fig.2. Formation of complexes between ABP and AFR at 
different protein concentrations. 2 ng of the mixture of end- 
labelled BumHI restriction fragments of Blur8 (short AFR and 
pBR322 vector fragment) were incubated in the presence of 
80 mM NaCl and 400 ng of non-labelled E. coli chromosomal 
DNA and increasing amounts of ABP (MQKK, fraction). The 
samples were processed as described in section 2 and in the 
legend to fig.1, and the radioautograph was analysed by 
densitometry. Maximal amount of added protein was 1 pg; the 
(expressed in ng). abscissa shows the extent of dilution (log scale). 
3. RESULTS 
The gel retention assay allows one to detect 
stable and specific protein-DNA complexes which 
appear as discrete bands in low salt polyacrylamide 
gel [ 16,171. When ABP is added to the end-labelled 
full-length AFR BamHI fragment mixed with in- 
creasing amounts of non-specific DNA (pBR322 
plasmid DNA), a characteristic series of bands is 
observed (fig.1, lane 4) of regularly decreasing 
mobility: complexes I, II, III, IV, etc. (CI, CII, 
CIII, CIV). In 4% polyacrylamide gel the com- 
plexes show a reproducibly decreased elec- 
trophoretic mobility (RA) relative to the free AFR 
fragment equal to 0.73 (CI), 0.57 (CII), 0.45 
(CIII), 0.34 (CIV). Low-mobility complexes ap- 
parently contain multiple molecules of bound pro- 
tein: a similar pattern was observed in experiments 
with lac-operator DNA and lac-repressor [171. 
The relative amount of each complex depends 
on the concentration of ABP (fig.2). At low pro- 
tein concentration only CII is seen, and the in- 
crease of protein concentration leads to a gradual 
disappearance of CII and formation of CI, CIII, 
CIV, etc.; CII with RA = 0.57 apparently contains 
a lower number of bound protein molecules as 
compared to CI which shows (figs 1,2) a higher 
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electrophoretic mobility (RA = 0.73). It is known 
that decreased electrophoretic mobility is char- 
acteristic of protein-DNA complexes with the ends 
of the DNA molecule draw% together which might 
be caused by DNA bending or looping [ 171. DNA 
looping promoted by the protein molecule bound 
at two widely separated sites permits cooperative 
binding at low protein concentrations [18]. 
To examine if AFR contains single or multiple 
binding sites for ABP we have isolated restriction 
subfragments of AFR produced by the cleavage of 
HinfI HinfI HinfI 
(BornHI) 4 h i (BarnHI) 
I :- I 
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Fig.3. Gel retention assay of differential binding of restriction 
subfragments of full-length AFR produced by nuclease Hinff. 
Short BumHI fragment from the plasmid Blur8 (full-length 
AFR) was cleaved with HinfI, subfragments were end-labelled 
with 32P using Klenow fragment of DNA polymerase and 
isolated by electrophoresis n polyacrylamide gel. DNA binding 
and gel retention assays were performed as described in section 
2 and in the legends to figs 1 and 2 using equimolar quantities 
of subfragments B, C and D (0.1-0.5 ng) incubated with a fixed 
amount of ABP (fraction MQa, 1 gg of protein) in the 
presence of 100 ng of non-labelled E. coli DNA and 80 mM 
NaCl. S-S, borders of Blur8 AFR flanked with BumHI 
sites; H, borders of consensus AFR [3]. Boxed are 
5 ’ GAGGC-3 ’ pentanucleotide tandems with 1 bp spacing. 
Lanes: 1 and 2, subfragment D without (-) and with (+) ABP; 
4 and 3, subfragment B without (-) and with (+) ABP; 5 and 
6, subfragment C without (-) and with (+) ABP. Upper 
arrows show the positions of Hid restriction sites [14] present 
in Blur8 AFR. 
full BumHI AFR fragment from Blur8 with 
nuclease HinfI, and used these subfragments as 
substrates.for ABP. It was found that AFR sub- 
fragments B, C, and D (fig.3) are able to interact 
with ABP forming discrete bands in the retarda- 
tion gel. Preference in binding measured as the 
percent of DNA in a complex shows that the 35 bp 
HinfI fragment B (fig.3) contains the sequence 
5 ’ -GAGGCTGAGAC-3 ’ [ 141 homologous to the 
sequence 5 ’ -GAGGCCGAGGC-3 ’ present in the 
T-antigen binding site II of the SV40 genome 
[ 11,121. The data on the binding of AFR sub- 
fragments uggest hat AFR contains multiple bin- 
ding sites for ABP and different sites vary in their 
affinity. The major binding site is situated in the 
middle part of AFR: nucleotides 163-197 [3]. It 
should be noted that HinfI subfragments C and D 
(fig.3) contain a GAGGC motif [3,14]. 
4. DISCUSSION 
Characteristic properties of Alu-repeat binding 
protein (ABP) described in this study and in our 
previous report [15] are its ability to form multiple 
protein-DNA complexes which have reproducible 
mobilities in retardation gels, as well as its ability 
to bind the 660 bp SV40 restriction fragment con- 
taining the replication origin [ 151. It is shown here 
that AFR contains multiple binding sites for ABP 
and that the major binding site is situated within a 
35 bp restriction fragment with the sequence 
5 ’ -GAGGCTGAGAC-3 ’ which could potentially 
explain the high-affinity interaction of ABP with 
the SV40 replication origin and with AFR. Binding 
specificity of ABP is clearly different from that of 
Spl [19] and of nuclear factor I [20]. Mouse 
nuclear protein was recently described [21] as 
enhancing T-antigen dependent replication of 
SV40 DNA in vitro and this protein might be 
similar to human ABP. 
The high-affinity complex formed between AFR 
and ABP at the lowest protein concentration (CII, 
figs 1 and 2) showed an anomalous electrophoretic 
mobility in retardation gels as compared to CI 
which should contain more bound protein 
molecules but showed a higher electrophoretic 
mobility than CII. Two models could explain this 
effect. First, ABP might induce DNA bending at 
the major binding site in the central part of AFR 
which should decrease the electrophoretic mobility 
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of CII [ 171, and CI is formed upon additional 
binding to CII of ABP or another protein possibly 
present in the MQ~oo fraction [15]. However, it is 
difficult to understand from this point of view the 
disappearance of DNA bent at the CII - CI 
transition. 
The second model suggests that CII is formed 
upon high-affinity cooperative binding of a single 
molecule of ABP to multiple sites within a single 
AFR molecule which induces DNA looping [18] 
and also should decrease the electrophoretic 
mobility [17]. The increase in concentration of 
ABP leads to the competitive displacement of 
cooperatively bound protein from some of the 
multiple binding sites and to the disappearance of 
the loop. 
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